Art

J-GLOBAL ID：201702242753368572   Reference number：17A0861537

Underlying Mechanisms and Therapeutic Strategies for Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ)

ビスホスホネート関連顎骨壊死(BRONJ)の根底機序と治療戦略

Author (7)： Endo Yasuo (Division of Oral and Maxillofacial Surgery, Graduate School of Dentistry, Tohoku University) ,  Kumamoto Hiroyuki (Division of Oral Pathology, Graduate School of Dentistry, Tohoku University) ,  Nakamura Masanori (Department of Oral Anatomy and Developmental Biology, School of Dentistry, Showa University) ,  Sugawara Shunji (Division of Oral Molecular Regulation, Graduate School of Dentistry, Tohoku University) ,  Takano-Yamamoto Teruko (Division of Orthodontics and Dentofacial Orthopedics, Graduate School of Dentistry, Tohoku University) ,  Sasaki Keiichi (Division of Advanced Prosthetic Dentistry, Graduate School of Dentistry, Tohoku University) ,  Takahashi Tetsu (Division of Oral and Maxillofacial Surgery, Graduate School of Dentistry, Tohoku University)
Material： Biological and Pharmaceutical Bulletin  (Biological & Pharmaceutical Bulletin)
Volume： 40  Issue： 6  Page： 739-750(J-STAGE)  Publication year： 2017 
JST Material Number： S0989A  ISSN： 0918-6158  CODEN： BPBLEO  Document type： Article
Article type： 文献レビュー  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： phosphate transporter

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0861537&from=J-GLOBAL&jstjournalNo=S0989A") }}

Author keywords (10)： bisphosphonate ,  osteonecrosis ,  inflammation ,  etidronate ,  clodronate ,  bisphosphonate ,  osteonecrosis ,  inflammation ,  etidronate ,  clodronate

JST classification (1)： Diseases of tooth and mouth(=oral cavity)  (GT03000G)

Substance index (2)： Etidronate ,  Clodronate

Reference (103)：

• 1) Fleisch H. Diphosphonates: history and mechanisms of actions. Metab. Bone Dis. Relat. Res., 3, 279-287 (1981).
• 2) Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J. Oral Maxillofac. Surg., 61, 1115-1117 (2003).
• 3) Migliorati CA. Bisphosphonates and oral cavity avascular bone necrosis. J. Clin. Oncol., 21, 4253-4254 (2003).
• 4) Fliefel R, Tröltzsch M, Kühnisch J, Ehrenfeld M, Otto S. Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review. Int. J. Oral Maxillofac. Surg., 44, 568-585 (2015).
• 5) Geddes AD, D’Souza SM, Ebetino FH, Kenneth JI. Bisphosphonates: structure-activity relationships and therapeutic implications. Bone and Mineral Research (Heershe NM, Kanis JK ed.) Vol. 8, Elsevier Science BV, Amsterdam, Holland, pp. 265-306 (1994).

Terms in the title (3)： ビスホスホネート関連顎骨壊死 ,  BRONJ ,  治療戦略